PHILLIP COMALANDER: Open Payments
NPI 1376086553 · FOLEY, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,266 in 113 payments from 12 companies in 2025. Trend: 2023 $952 · 2024 $1,625 · 2025 $2,266
Food & beverage: $2,266
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 40 | $670 |
| Madrigal Pharmaceuticals | 12 | $539 |
| Phathom Pharmaceuticals, Inc. | 18 | $248 |
| Janssen Biotech, Inc. | 12 | $204 |
| Lilly USA, LLC | 10 | $183 |
| Gilead Sciences, Inc. | 6 | $116 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $104 |
| Ardelyx, Inc. | 4 | $66 |
| Regeneron Healthcare Solutions, Inc. | 2 | $54 |
| Novo Nordisk Inc | 2 | $28 |
Products named: REZDIFFRA, VOQUEZNA, TREMFYA, RINVOQ, SKYRIZI, OMVOH, CREON, LINZESS.
Industry payments across AL — which companies pay providers there.
